ZIVO Bioscience, Inc.

ZIVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 24, 2026
EFFECT Apr 1, 2026
15-12G Mar 31, 2026 15-12G
S-8 POS Mar 31, 2026 S-8
POS AM Mar 31, 2026 POS AM
8-K Mar 30, 2026 FORM 8-K
4 Mar 3, 2026 PRIMARY DOCUMENT
SCHEDULE 13D/A Feb 27, 2026
4 Feb 17, 2026
4 Feb 12, 2026 PRIMARY DOCUMENT
4 Jan 28, 2026 PRIMARY DOCUMENT
4 Jan 28, 2026 PRIMARY DOCUMENT
4 Jan 27, 2026 PRIMARY DOCUMENT
4 Jan 27, 2026 PRIMARY DOCUMENT
3 Dec 29, 2025 3
8-K Dec 23, 2025 FORM 8-K
4 Dec 2, 2025 PRIMARY DOCUMENT
10-Q Nov 14, 2025 FORM 10-Q
4 Oct 20, 2025
4 Oct 14, 2025 PRIMARY DOCUMENT
4 Oct 9, 2025 PRIMARY DOCUMENT
4 Oct 6, 2025 PRIMARY DOCUMENT
4 Oct 6, 2025 PRIMARY DOCUMENT
4 Oct 6, 2025 PRIMARY DOCUMENT
4 Oct 2, 2025 PRIMARY DOCUMENT
← Newer Page 1 of 31 · 756 filings Older →